Regulated information

Rapport financier semestriel 2011 (french)

> Rapport d’activité semestriel 2011
<br>> Etats financiers consolidés résumés au 30 juin 2011
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2011

Rapport financier semestriel 2012 (french)

> Rapport d&rsquo;activité semestriel 2012
<br>> Etats financiers consolidés résumés au 30 juin 2012
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2012

Rapport financier semestriel 2014 (french)

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

Rapport semestriel Vétoquinol 2008 (french)

Vétoquinol a réalisé de bons résultats au premier semestre 2008 : le chiffre d’affaires
progresse de 5,0% et le résultat net après impôts de 15,3%.

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

Vétoquinol: H1 2008 interim earnings

Vétoquinol: H1 2009 interim earnings

Vétoquinol: H1 2009 interim earnings

1.‘Hybrid’ growth
<br>2.Stronginterimresults
<br>3.Focus on twostrategicpillars:
<br>- Innovation throughR&D
<br>- Potentialfor externalgrowth
<br>4.Questions and answers